Trials / Conditions / Recurrent Clostridium Difficile Infection

Recurrent Clostridium Difficile Infection

13 registered clinical trials studyying Recurrent Clostridium Difficile Infection — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	VE303 for Prevention of Recurrent Clostridioides Difficile Infection NCT06237452	Vedanta Biosciences, Inc.	Phase 3
Unknown	Fecal Filtrate as a Treatment Option of Multiple Recurrent Clostridioides Difficile Infection NCT04960306	University of Pecs	Phase 3
Completed	Dietary Optimization of Microbiome Recovery Following Fecal Microbiota Transplantation NCT05826418	University of Minnesota	N/A
Completed	Primary or Recurrent Clostridioides Difficile Infection Treatment With Capsules of Lyophilised Faecal Microbio NCT05201079	Mikrobiomik Healthcare Company S.L.	Phase 3
Terminated	Penn Microbiome Therapy for Recurrent Clostridium Difficile Infection NCT03973697	University of Pennsylvania	Phase 2
Completed	Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection NCT03462459	University of Wisconsin, Madison	Phase 2
Completed	Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurr NCT03497806	Finch Research and Development LLC.	Phase 2
Completed	Lyophilized Fecal Transplant vs Lyophilized Fecal Filtrate in Recurrent C Diff Infection NCT03353506	Dina Kao	Phase 2
Completed	Lyophilized Fecal Microbiota Transplantation for Recurrent Clostridioides Difficile Infection NCT03834038	Vancouver Island Health Authority	N/A
Completed	Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea NCT01925417	Rebiotix Inc.	Phase 2
Terminated	Oral Vancomycin Followed by Fecal Transplant Versus Tapering Oral Vancomycin NCT01226992	University Health Network, Toronto	Phase 2 / Phase 3
Suspended	BIO-K+ CL1285 for Prevention of Recurrent Clostridium Difficile Infection NCT01202630	Bio-K Plus International Inc.	Phase 3
Available	Fecal Microbiota Transplantation (FMT): PRIM-DJ2727 NCT03786900	Herbert DuPont, MD	—